Wall Street brokerages expect Encompass Health Co. (NYSE:EHC – Get Rating) to report sales of $1.35 billion for the current quarter, according to Zacks. Five analysts have made estimates for Encompass Health’s earnings, with estimates ranging from $1.33 billion to $1.37 billion. Encompass Health posted sales of $1.29 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.7%. The firm is scheduled to issue its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Encompass Health will report full year sales of $5.43 billion for the current year, with estimates ranging from $5.32 billion to $5.46 billion. For the next year, analysts forecast that the firm will report sales of $5.88 billion, with estimates ranging from $5.72 billion to $5.97 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Encompass Health.
Encompass Health (NYSE:EHC – Get Rating) last issued its earnings results on Wednesday, April 27th. The company reported $0.97 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.32 billion. Encompass Health had a return on equity of 19.20% and a net margin of 8.05%. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the business posted $1.05 EPS.
EHC stock opened at $68.36 on Friday. The company has a market capitalization of $6.80 billion, a P/E ratio of 16.63, a price-to-earnings-growth ratio of 2.49 and a beta of 0.99. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.23 and a current ratio of 1.23. Encompass Health has a 52-week low of $56.31 and a 52-week high of $88.58. The business has a 50-day simple moving average of $69.25 and a two-hundred day simple moving average of $65.96.
The firm also recently announced a quarterly dividend, which was paid on Monday, April 18th. Shareholders of record on Friday, April 1st were issued a dividend of $0.28 per share. The ex-dividend date was Thursday, March 31st. This represents a $1.12 dividend on an annualized basis and a yield of 1.64%. Encompass Health’s payout ratio is 27.25%.
A number of hedge funds have recently modified their holdings of the business. BlackRock Inc. raised its holdings in Encompass Health by 1.4% during the 4th quarter. BlackRock Inc. now owns 10,643,463 shares of the company’s stock valued at $694,594,000 after acquiring an additional 145,130 shares during the period. Wellington Management Group LLP grew its position in shares of Encompass Health by 5.8% during the 3rd quarter. Wellington Management Group LLP now owns 8,181,371 shares of the company’s stock valued at $613,929,000 after purchasing an additional 450,688 shares in the last quarter. State Street Corp grew its position in shares of Encompass Health by 1.2% during the 4th quarter. State Street Corp now owns 2,602,750 shares of the company’s stock valued at $170,580,000 after purchasing an additional 29,795 shares in the last quarter. TimesSquare Capital Management LLC grew its position in shares of Encompass Health by 0.8% during the 3rd quarter. TimesSquare Capital Management LLC now owns 1,408,245 shares of the company’s stock valued at $105,675,000 after purchasing an additional 11,425 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of Encompass Health by 14.0% during the 4th quarter. Invesco Ltd. now owns 1,389,517 shares of the company’s stock valued at $90,679,000 after purchasing an additional 170,155 shares in the last quarter. 92.35% of the stock is currently owned by institutional investors and hedge funds.
About Encompass Health (Get Rating)
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
- Harley-Davidson Skids Into A Buying Opportunity
- Facebook (NASDAQ: FB) Soars And Wall Street Delights
- Automatic Data Processing Is Ready To Scale New Heights
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.